Fig. 2From: Prognostic significance of baseline T cells, B cells and neutrophil-lymphocyte ratio (NLR) in recurrent ovarian cancer treated with chemotherapyPrognostic impact of baseline immune subsets in recurrent ovarian cancer patients receiving chemotherapy. A favorable prognostic impact was seen with high baseline T cells and B cells. Baseline blood neutrophils had no prognostic impact. High baseline neutrophil lymphocyte ratio (NLR) was associated with a poor prognosisBack to article page